Drug Distribution and Pharmacodynamic Study of Pulsatile Lapatinib in Surgically Accessible EGFR-Amplified Recurrent High-Grade Glioma
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Lapatinib (Primary)
- Indications Glioblastoma; Glioma; Gliosarcoma
- Focus Pharmacodynamics; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 11 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2018.
- 11 Jul 2016 Status changed from suspended to recruiting.